Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep319 | Pituitary and Neuroendocrinology | ECE2024

Gender related metabolic differences in hypopituitarism

Miljic Dragana , Nikolic Djurovic Marina , Doknic Mirjana , Djurdjevic Sandra , Stojanovic Marko , Jemuovic Zvezdana , Cekic Ivana , Jevtic Ivan , Petakov Milan

Background: Hypopituitarism is characterised by multiple pituitary hormone deficiencies causing adverse metabolic milleu and body composition changes. Aim: Our aim was to investigate the gender related differences in the prevalence of metabolic syndrome (MetS) and metabolic profiles in patients with hypopituitarism compared to obese controls. Patients and methods: A retrospective study of 282 patients with hypopituitarism (136 wome...

ea0081ep649 | Pituitary and Neuroendocrinology | ECE2022

Lipid accumulation product (LAP) as surrogate marker of fatty liver in patients with Cushing’s disease (CD)

Miljic Dragana , Djurdjevic Sandra Pekic , Doknic Mirjana , Stojanovic Marko , Djurovic Marina Nikolic , Jemuovic Zvezdana , Radovic Sara , Radić Nevena , Petakov Milan

Introduction: The most common etiology of endogenous Cushing’s syndrome (CS) is Cushing’s disease (CD). Patients with CS also represent a model of patients with metabolic syndrome (MetS) with associated increased cardiovascular morbidity and mortality. Insulin resistance and obesity, two major characteristics of CS, lead to the accumulation of triglycerides within hepatocytes and formation of fatty liver in these patients.Aim: To evaluate the p...

ea0081ep670 | Pituitary and Neuroendocrinology | ECE2022

Xantho-granulomatous hypophysitis: analysis of clinical, biochemical, radiological and etiological characteristics

Miljic Dragana , Djurdjevic Sandra Pekic , Doknic Mirjana , Stojanovic Marko , Djurovic Marina Nikolic , Jemuovic Zvezdana , Milojevic Toplica , Milicevic Mihailo , Gacic Emilija Manojlovic , Jovanovic Jovan , Medenica Sanja , Petakov Milan

Introduction: Xanthomatous hypophysitis (XH) is characterized by inflammatory infiltration of the pituitary gland in which lipid laden macrophages predominate. It can be primary (3% of all primary hypophysitis) and secondary arising in the setting of other lesions: craniopharyngioma, Rathke’s cleft cyst (RCC), adenomas (with subclinical apoplexy). It is more common in women and younger people. The clinical presentation is similar to pituitary tumors and may prese...

ea0081ep761 | Pituitary and Neuroendocrinology | ECE2022

Skeletal complications in Cushing’s disease (CD)

Miljic Dragana , Djurdjevic Sandra Pekic , Doknic Mirjana , Stojanovic Marko , Djurovic Marina Nikolic , Jemuovic Zvezdana , Radić Nevena , Radovic Sara , Petakov Milan

Introduction: Structural and functional damage of the skeletal system resulting in fractures is a common complication of CD. Due to major effect of glucocorticoids on the trabecular bone, vertebral fractures are a common and severe complication which can lead to disability.Goal: To investigate the prevalence of skeletal complications (osteoporosis, osteopenia, presence of fragility fractures) in patients with Cushing’s disease, as well as gain insig...

ea0086oc3.3 | Reproductive and Neuroendocrinology | SFEBES2022

Long-term efficacy and safety of oral, once-daily paltusotine treatment in acromegaly: Two-year interim results from the ACROBAT Advance study

Randeva Harpal , Gadelha Monica , Gordon Murray , Doknic Mirjana , Mezősi Emese , Toth Miklos , Boguszewski Cesar , Ferrara-Cook Christine , Casagrande Alessandra , Krasner Alan

Paltusotine is an investigational oral, once-daily, non-peptide, SST2 agonist in development for the treatment of acromegaly and neuroendocrine tumors. Interim analysis results from subjects with acromegaly treated with paltusotine for up to 2 years in ACROBAT Advance (NCT04261712), an ongoing, open-label extension study are reported here. Prior to Advance, subjects previously completed one of two Phase 2 parent studies, Evolve (NCT03792555, with normal IGF-1 using injected lo...

ea0067gp37 | Poster Presentations | EYES2019

Calcium infusion test in primary hyperparathyroidism- sensitivity of calcium sensing receptor, possible new theories?

Muzurovic Emir , Pekic Sandra , Djurovic Marina , Miljic Dragana , Stojanovic Marko , Doknic Mirjana , Jemuovic Zvezdana , Vujošević Snežana , Šahmanović Benida , Petakov Milan

Objective: Ionized calcium via calcium sensing receptors (CaSR) mediates feedback inhibition of parat hormone (PTH) secretion. The aim of this study is to evaluate the difference in PTH response during calcium infusion test (CIT), between patients with primary hyperparathyroidism (PHPT) and healthy control (HC).Methods: Study consisted of 15 patients with confirmed PHPT and parathyroid adenoma (57.20±11.38yrs) and 15 healthy subjects-HC (57.20±...

ea0063p236 | Pituitary and Neuroendocrinology 1 | ECE2019

Serum aryl hydrocarbon receptor-interacting protein (AIP) levels are independent of serum GH levels both at baseline and in dynamic tests of GH stimulation and suppression

Stojanovic Marko , Wu Zida , Stiles Craig , Miljic Dragana , Soldatovic Ivan , Pekic Sandra , Doknic Mirjana , Petakov Milan , Popovic Vera , Strasburger Christian , Korbonits Marta

Background and aim: Aryl hydrocarbon receptor-interacting protein (AIP) is evolutionary conserved and widely distributed throughout organism. Broad interest for AIP comes from involvement of loss-of-function AIP mutations in pituitary adenoma pathogenesis. The role of AIP in normal pituitary function is largely unknown. AIP is co-localized with GH in somatotroph secretory vesicles. Serum AIP protein was proteomically identified. We aimed at investigating whether AIP and GH are...

ea0049ep954 | Pituitary - Clinical | ECE2017

Changes in pituitary tumour biology and behaviour in FIPA patient with GH secreting aggressive pituitary macro adenoma

Miljic Dragana , Pekic Sandra , Doknic Mirjana , Nikolic-Djurovic Marina , Stojanovic Marko , Manojlovic-Gacic Emilija , Korbonits Marta , Trouillas Jaqueline , Vasiljevic Alexandre , Popovic Vera , Petakov Milan

40-year-old female patient presented with acromegaly in 2008 (GH 61 (g/L, IGF-1 774 ng/ml PRL 1500 mU/L). Macro-adenoma invading the right cavernous sinus was found on MRI and she underwent two pituitary surgeries revealing sparsely granulated GH adenoma with scattered PRL cells, low Ki 67 and negative p53 immuno-staining. Her second cousin was treated for macro prolactinoma. Both patients tested negative for germline mutations in the AIP and menin genes. Treatment with somato...

ea0049ep956 | Pituitary - Clinical | ECE2017

Rare causes of hypopituitarism in adults in a tertiary care institution

Djurdjevic Sandra Pekic , Doknic Mirjana , Miljic Dragana , Stojanovic Marko , Djurovic Marina Nikolic , Jemuovic Zvezdana , Stojanoska Milica Medic , Popovic Vera , Petakov Milan

Objective: Hypopituitarism is a rare disease,a pituitary adenoma and is treatment being the most common cause of it. In recent years there is increased reporting of rare causes of hypopituitarism acquired in adulthood, such as other sellar and parasellar masses, brain damage caused by radiation and traumatic brain injury (TBI), vascular lesions, infiltrative/immunological/inflammatory diseases and infectious diseases. Aim of our study was to increase the awareness to these rar...

ea0041ep735 | Neuroendocrinology | ECE2016

Phenotype-genotype analysis in patients with GnRH deficiency in a single center

Djurdjevic Sandra Pekic , Xu Cheng , Dwyer Andrew , Cassatella Daniele , Doknic Mirjana , Miljic Dragana , Stojanovic Marko , Petakov Milan , Pitteloud Nelly , Popovic Vera

Objective: Congenital hypogonadotropic hypogonadism (CHH) results from isolated GnRH deficiency and may present with normal sense of smell (nCHH), anosmia (Kallmann syndrome, KS) or in syndromic forms. Genetic defects are identified in approximately half of CHH cases and oligogenicity is noted in almost 10%. Further, spontaneous reversal of is seen in 15% of patients.Methods: We analyzed the clinical characteristics of 37 Serbian CHH probands (34 sporadi...